New Generic Ampyra To Improve Walking for People with MS Is Available Now

New generic Ampyra is available now. You can save almost 80% by ordering from a Canadian mail order pharmacy.

Dalfampridine (Ampyra) is an oral medication, in tablet form, which blocks tiny pores called potassium channels on the surface of nerve fibers. Blocking potassium channels may improve the conduction of nerve signals along nerve fibers whose insulating myelin coating has been damaged by multiple sclerosis (MS).

MS is a disease in which the nerves do not function properly and may cause weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control.

Dalfampridine is approved by the U.S. Food and Drug Administration (FDA) to improve walking in patients with multiple sclerosis, as demonstrated by an increase in walking speed. However, this medication is not a cure for MS.

The average retail price for the most common version of generic Ampyra (10 mg) is around $43.14 per tab in the United States (source from goodrx.com), while the brand Ampyra (Fampyra) manufactured by Biogen from Canada mail order pharmacy is only $13.66 per tab.

Compare Prices Between Brand and Generic Ampyra And See the Cost Savings!

CanadaOnlineHealth.com carries both brand Ampyra (Fampyra) and generic Ampyra (Taro Fampridine) from Canada. You can save almost 80% from the CIPA (Canadian International Pharmacy Association) certified pharmacy.